A new study shows how scientists used two complementary cell reprogramming methods to create mutation-free lines of stem cells from human patients with mitochondrial diseases.
A new study shows how scientists used two complementary cell reprogramming methods to create mutation-free lines of stem cells from human patients with mitochondrial diseases.